Awakn Life Sciences Corp. (OTCMKTS:AWKNF) Sees Large Drop in Short Interest

Awakn Life Sciences Corp. (OTCMKTS:AWKNF) was the target of a large decline in short interest in November. As of November 15th, there was short interest totalling 100 shares, a decline of 98.6% from the October 31st total of 7,100 shares. Based on an average trading volume of 44,400 shares, the days-to-cover ratio is currently 0.0 days.

Awakn Life Sciences Price Performance

Shares of AWKNF traded up $0.01 during midday trading on Friday, hitting $0.09. The company had a trading volume of 3,119 shares, compared to its average volume of 15,564. The company’s 50 day moving average price is $0.08 and its 200 day moving average price is $0.09. Awakn Life Sciences has a 52 week low of $0.05 and a 52 week high of $0.19.

Awakn Life Sciences Company Profile

Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company has a collaboration agreement with the University of Exeter for exploring the use of ketamine-assisted therapy to treat Severe AUD.